#fda-regulations

[ follow ]
#mifepristone
US politics
fromwww.nytimes.com
3 months ago

Abortion Pill Maker Enters Legal Fight Over F.D.A. Rules

GenBioPro seeks to defend mifepristone in a major legal battle against Republican state attorneys general aiming to limit abortion access.
US politics
fromwww.nytimes.com
3 months ago

Abortion Pill Maker Enters Legal Fight Over F.D.A. Rules

GenBioPro seeks to defend mifepristone in a major legal battle against Republican state attorneys general aiming to limit abortion access.
more#mifepristone
#pharmaceuticals
Alternative medicine
fromWIRED
1 month ago

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

FDA allowed compounding pharmacies a grace period to cease production post-drug shortage, but some continue to sell modified tirzepatide products.
Alternative medicine
fromWIRED
1 month ago

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

FDA allowed compounding pharmacies a grace period to cease production post-drug shortage, but some continue to sell modified tirzepatide products.
more#pharmaceuticals
#food-safety
SF food
fromFast Company
1 month ago

RFK Jr. to phase out 8 widely used food dyes

U.S. health officials plan to phase out eight petroleum-based artificial colors from food, replacing them with natural substitutes.
fromNew York Post
1 month ago
SF food

8 harmful dyes will soon be phased out of US food under plans unveiled by FDA, RFK Jr. - here's what could be next

SF food
fromFast Company
1 month ago

RFK Jr. to phase out 8 widely used food dyes

U.S. health officials plan to phase out eight petroleum-based artificial colors from food, replacing them with natural substitutes.
fromNew York Post
1 month ago
SF food

8 harmful dyes will soon be phased out of US food under plans unveiled by FDA, RFK Jr. - here's what could be next

more#food-safety
#weight-loss-drugs
fromFast Company
1 month ago
Startup companies

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Startup companies
fromFast Company
1 month ago

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.
more#weight-loss-drugs
fromwww.theguardian.com
1 month ago

The Trump administration is defending abortion pill access in court. What?

The Trump administration's request to dismiss the mifepristone lawsuit appears as a defense of the drug, despite the president's history of rolling back abortion rights.
US politics
#health-risks
Miscellaneous
fromFuturism
6 months ago

People Are Getting Their Eyeballs Tattooed

Keratopigmentation is a risky procedure for changing eye color, raising concerns from medical professionals about potential damage to vision.
Miscellaneous
fromFuturism
6 months ago

People Are Getting Their Eyeballs Tattooed

Keratopigmentation is a risky procedure for changing eye color, raising concerns from medical professionals about potential damage to vision.
more#health-risks
fromwww.npr.org
2 months ago

Patients scramble as cheaper obesity drug alternatives disappear

They've each lost about 20 pounds in six weeks. But the Agars, who live in Minnesota, aren't taking Eli Lilly's Zepbound; their insurance doesn't cover it.
Alternative medicine
fromWhoWhatWear
2 months ago

Sunscreen Filters Abroad Are Totally Elite-Here's Why They're Not Available in the U.S. Yet

"The last time an OTC sunscreen ingredient was approved in the U.S. was in the '90s, causing frustration among professionals and companies.
US news
Miscellaneous
fromInsideHook
4 months ago

One Super Bowl Ad Is Attracting Bipartisan Pushback

The Super Bowl ad for Hims & Hers is under scrutiny for lacking mandatory disclosures required for pharmaceutical ads.
[ Load more ]